Side-by-side comparison of AI visibility scores, market position, and capabilities
Binx Health develops FDA-cleared point-of-care molecular diagnostic platforms delivering chlamydia and gonorrhea results in 30 minutes at doctors offices; raised $280M total including $65M Series F in 2024; backed by EQT and OrbiMed.
Binx Health is a molecular diagnostics company founded in 2012 and headquartered in Boston, Massachusetts. The company develops point-of-care (POC) molecular testing platforms designed to bring lab-quality STI diagnostics to clinical settings outside traditional centralized laboratories — including physicians'' offices, urgent care clinics, pharmacies, and hospital emergency departments. Binx''s flagship platform, the binx io system, is FDA-cleared and CLIA-waived, enabling non-laboratory staff to perform certified molecular tests for chlamydia and gonorrhea with results delivered in approximately 30 minutes. CLIA-waiver status is critical because it allows the system to be operated in any point-of-care setting without requiring a laboratory director.
Epic holds over 42% of U.S. acute care hospital EHR market share and is embedding AI across 150+ clinical workflows for 2026, while facing antitrust scrutiny.
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale electronic health record systems and reports that more than 305 million patients have a record in Epic, covering the majority of U.S. academic medical centers and large health systems including Kaiser Permanente, Mayo Clinic, Johns Hopkins, and Cleveland Clinic. Epic commands approximately 42% of U.S. acute care hospitals and nearly 55% of acute care hospital beds, making it the undisputed market leader in enterprise EHR.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.